{"name":"BOSECO LIMITED","company_number":"06449999","status":"Active","type":"Private Limited Company","incorporated":"2007-12-11","dissolved":null,"registered_office":"Boss Drive, Off New Road, Dudley, West Midlands, DY2 8SZ","postcode":"DY2 8SZ","sic_codes":[{"code":64999,"description":"Financial intermediation not elsewhere classified"},{"code":68209,"description":"Other letting and operating of own or leased real estate"}],"principal_activity":"The principal activity of the company is to act as a holding company for its subsidiary undertakings. The principal activity of the subsidiary undertakings continued to be the design, manufacture and supply of contract seating and associated furniture to the commercial sector.","previous_names":[],"warnings":[],"accounts":{"category":"Group","year_end":"31 March","last_made_up_to":"2025-03-31","next_due":"2026-12-31"},"employees":{"count":262,"accounts_date":"2025-03-31"},"financials":[{"financial_date":"2025-03-31","profit_loss":731477,"net_assets":19892764,"cash":7684893,"average_employees":262},{"financial_date":"2024-03-31","profit_loss":270029,"net_assets":19172017,"cash":5547718,"average_employees":274},{"financial_date":"2023-03-31","cash":1048},{"financial_date":"2022-03-31","cash":1108},{"financial_date":"2021-03-31","turnover":26643961,"cash":1153}],"officers":{"current":3,"resigned":0,"complete":true,"note":"Names and details of individual officers are on the People page (subscriber-only on this site) and free at Companies House."},"charges":{"total":0,"outstanding":0},"gazette_notices":[],"insolvency_outcome":null,"ai_summary":"Boseco Limited exhibits exceptional financial resilience with a debt-free balance sheet, £19.9m in net assets, and cash reserves that have grown from £1,048 in 2023 to £7.7m in 2025 — a transformation that speaks to strong cash generation capabilities. However, the diagnosis reveals a business that is financially robust but operationally constrained, with thin operating margins of just 2.2% on £45m turnover and no revenue growth. The prognosis is cautiously optimistic given the company's investment in sustainability, product development, and manufacturing efficiency, but the primary prescription must focus on margin expansion and strategic deployment of the substantial cash reserves to drive growth and shareholder returns.","website":null,"links":{"page":"https://www.companiesintheuk.co.uk/ltd/boseco","people":"https://www.companiesintheuk.co.uk/company/boseco/people","filing_history":"https://www.companiesintheuk.co.uk/company/boseco/filing-history","companies_house":"https://find-and-update.company-information.service.gov.uk/company/06449999","financials":"https://www.companiesintheuk.co.uk/company/boseco/financial","control":"https://www.companiesintheuk.co.uk/company/boseco/control","charges":"https://www.companiesintheuk.co.uk/company/boseco/charges","ai_analysis":"https://www.companiesintheuk.co.uk/company/boseco/analysis"},"source":"CompaniesInTheUK, from Companies House, The Gazette and other public registers (see /support/about). Cite as: CompaniesInTheUK, https://www.companiesintheuk.co.uk/ltd/boseco"}